We focus on sustainable, long-term weight lossnot crash diets
What "long-term" means in context It's important to recognize that while current data extends to two to three years, GLP-1 medications for obesity are relatively new, and we're still learning about effects beyond this timeframe
Continuous, long-term administration is where problems can arise
It is currently being studied for the management of obesity, insulin resistance, and metabolic disease through the Phase 3 TRIUMPH program
On the other hand, as a signaling molecule, ROS activates vital signaling pathways that are crucial to promote the onset and progression of gastric cancer
Side effects, dosing strategies, and individual health history must be carefully evaluated